Viewing nowSitaglm 25 mg Tablet (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Mothers Pharmaceuticals Co., Ltd.

MFDS item code 202101175 · Approved 2021.02.08 · Insurance code 622804840
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used in combination with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be given as monotherapy if blood sugar control is difficult, and if a patient has not previously used diabetes medications but struggles with monotherapy, it can be combined with metformin. Additionally, it can enhance effect when used together with sulfonylureas, metformin, thiazolidinediones, or insulin when monotherapy does not provide adequate control. Furthermore, if blood sugar control is still difficult with various combination therapies, this medication can be used additionally to improve treatment. This medication assists in comprehensively improving blood sugar control.
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, section 5, General Precautions). As dose adjustment is required according to renal function, assessment of renal function before and periodically after starting this medicine is recommended. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This medication may rarely cause serious allergic reactions. Such reactions can include anaphylaxis, angioedema, and severe skin conditions. Symptoms may appear within the first 3 months of taking the drug, so caution is necessary. If an allergic reaction is suspected, stop taking the medication immediately and consult a healthcare professional. Moreover, this medication can cause serious side effects, such as acute pancreatitis, which involves inflammation of the pancreas, so if symptoms like abdominal pain, vomiting, or loss of appetite occur during treatment, prompt medical attention is necessary. This medication is not to be used by patients with type 1 diabetes or diabetic ketoacidosis. Also, patients who are allergic to this drug or its components should not take it. For patients with reduced kidney function, dose adjustment is necessary, and regular kidney function tests are important. Common side effects reported in clinical trials include upper respiratory infection, nasopharyngitis, headache, diarrhea, etc., and symptoms of hypoglycemia may occur, so blood sugar management must be monitored closely. Especially when taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, so dose adjustments for these medications may be needed. This medication is not recommended during pregnancy, and it is also advisable for breastfeeding women to avoid taking it. For elderly patients, dose adjustments and monitoring of kidney function are necessary due to the potential for decreased kidney function. In case of overdose, appropriate treatment such as gastrointestinal decontamination and ECG monitoring should be undertaken, and some may be removed by hemodialysis. If symptoms like joint pain or skin blisters or rash occur during treatment, notify healthcare professionals immediately, and if necessary, consider stopping the medication and consulting a specialist. This medication has a low potential for interactions with other medications; however, monitoring is necessary when taking digoxin. Lastly, this medication poses no issues concerning cardiovascular safety and does not increase the risk of heart disease with long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly closed container to avoid exposure to air or humidity, and it is best stored at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
Pink, biconvex, round film-coated tablet
28 tablets/PPT[(14 tablets/PTPx2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Mothers Pharmaceuticals Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.